Olmesartan may cause chronic diarrhea and weight loss. A recent lawsuit against the makers of Olmesartan medoxomil lead to a 300 million dollar settlement
“Severe Spruelike Enteropathy Associated With Olmesartan” – Mayo Clinic
The link between Benicar (the trade name of the drug Olmesartan medoxomil) and sprue-like enteropathy was first observed at the Mayo Clinic in 2012.
Olmesartan Medoxomil is present in olmezest, and these commonly prescribed drugs.
The blood pressure medication Benicar (olmesartan medoxomil)—and its sister drugs Benicar HCT, Azor, and Tribenzor—have been linked to serious gastrointestinal injury, prompting thousands of lawsuits against drug maker Daiichi Sankyo
Lawsuits against the makers of Olmesartan Medoxomil lead to a 300 Million Dollar settlement